Determination of the antileukemic drug mitoguazone and seven other closely related bis(amidinohydrazones) in human blood serum by high-performance liquid chromatography

Journal of Chromatography B: Biomedical Applications

Volumn 685, Issue 1, 1996, Pages 141-149

  Koskinen, M ^a   Elo, H ^a   Lukkari, P ^a   Riekkola, M L ^a  

^a NONE

Author keywords

Bis(amidinohydrazones); Bis(guanylhydrazones); Mitoguazone

Indexed keywords

ANTILEUKEMIC AGENT; GLYOXAL DERIVATIVE; MITOGUAZONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MIXTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TECHNIQUE; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0030580044     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-4347(96)00126-0     Document Type: Article

References (52)

1. [1] H.G. Williams-Ashman and J. Seidenfeld, Biochem. Pharmacol., 35 (1986) 1217.
2. [2] H. Elo, Ph.D. Thesis, University of Helsinki, Helsinki, 1989.
3. [3] L. Alhonen-Hongisto, P. Seppänen, P. Nikula, H. Elo and J. Jänne, Recent Progr. Polyamine Res., (1985) 261.
4. [4] J. Jänne, L. Alhonen-Hongisto, P. Nikula and H. Elo, Adv. Enz. Regul., 24 (1986) 125.
5. [5] J. Jänne, L. Alhonen and P. Leinenen, Ann. Med., 23 (1991) 241.
6. [6] H. Elo, I. Mutikainen, L. Alhonen-Hongisto, R. Laine and J. Jänne, Cancer Lett., 41 (1988) 21.
7. [7] H. Elo, I. Mutikainen, L. Alhonen-Hongisto, R. Laine, J. Jänne and P. Lumme, Z. Naturforsch., 41 (1986) 851.
8. [8] H. Elo, Chemotherapy, 36 (1990) 373.
9. [9] P. Seppänen, R. Fagerström, L. Alhonen-Hongisto, H. Elo, P. Lumme and J. Jänne, Biochem. J., 221 (1984) 483.
10. [10] L. Alhonen-Hongisto, R. Fagerström, R. Laine, H. Elo and J. Jänne, Biochem. J., 221 (1984) 273.
11. [11] R.P. Warrell, B.J. Lee, S.J. Kempin, M.J. Lacher, D.J. Straus and C.W. Young, Blood, 57 (1981) 1011.
12. [12] R.F. Todd, M.B. Garnick, G.P. Ganellos, J.P. Richie, R.F. Gittes, R.J. Mayer and A.T. Skarin, Cancer Treat. Rep., 65 (1981) 17.
13. [13] W.A. Knight, R.B. Livingston, C. Fabian and J. Costanzi, Cancer Treat. Rep., 63 (1979) 1933.
14. [14] B.I. Shnider, J. Colsky, R. Jones and P.P. Carbone, Cancer Chemother. Rep., 58 (1974) 689.
15. [15] G. Falkson, Cancer Chemother. Rep., 55 (1971) 209.
16. [16] J. Zeffren, A. Yagoda, R.C. Watson, R.B. Natale, M.S. Blumenreich, R. Chapman and J. Howard, Cancer Treat. Rep., 65 (1981) 525.
17. [17] H.-Y. Yap, G.R. Blumenschein, F. Schell and G.P. Bodey, Cancer Treat. Rep., 65 (1981) 465.
18. [18] W. Regelson and J.F. Holland, Cancer Chemother. Rep., 11 (1961) 81.
19. [19] E.J. Freireich, E. Frei and M. Karon, Cancer Chemother. Rep., 16 (1962) 183.
20. [20] R.H. Levin, G.M. Brittin and E.J. Freireich, Blood, 21 (1963) 689.
21. [21] T.A. Splinter and J.C. Romijin, Eur. J. Cancer Clin. Oncol., 22 (1986) 61.
22. [22] A.-M. Maddox, E.J. Freireich, M.J. Keating and M.K. Haddox, Cancer Res., 48 (1988) 1367.
23. [23] M. Siimes, P. Seppänen, L. Alhonen-Hongisto and J. Jänne, Int. J. Cancer, 28 (1981) 567.
24. [24] A.E. Pegg and P.P. McCann, Pharm. Ther., 56 (1992) 359.
25. [25] H.G. Williams-Ashman and A. Schenone, Biochem. Biophys. Res. Commun., 46 (1972) 288.
26. [26] E. Hölttä, P. Hannonen, J. Pispa and J. Jänne, Biochem. J., 136 (1973) 669.
27. [27] A.E. Pegg and S.M. McGill, Biochem. Pharmacol., 27 (1978) 1625.
28. [28] J. Jänne and D.R. Morris, Biochem. J., 218 (1984) 947.
29. [29] H. Elo, R. Laine, L. Alhonen-Hongisto, J. Jänne, I. Mutikainen and P. Lumme, Z. Naturforsch., 40c (1985) 839.
30. [30] H. Elo and I. Mutikainen, Z. Naturforsch., 43c (1988) 601.
31. [31] J. Stanek, G. Caravatti, H.-G. Capraro, P. Furet, H. Mett, P. Schneider and U. Regenass, J. Med. Chem., 36 (1993) 46.
32. [32] U. Regenass, H. Mett, J. Stanek, M. Mueller, D. Kramer and C.W. Porter, Cancer Res., 54 (1994) 3210.
33. [33] J. Roboz, K.T. Wu and R.D. Hart, J. Anal. Toxicol., 4 (1980) 127.
34. [34] M.G. Rosenblum and T.L. Loo, J. Chromatogr., 183 (1980) 363.
35. [35] K.C. Marsh, AJ. Repta and L.A. Sternson, J. Chromatogr., 187 (1980) 101.
36. [36] D.L. Gildersleeve, M.C. Tobes and R.B. Natale, Clin. Chem., 31 (1985) 1979.
37. [37] A. Negro, R. Méndez, J. Martin-Villacorta, A.I. Ortiz and D. Ordóñez, J. Liq. Chromatogr., 14 (1991) 2409.
38. [38] S. Kourou-Daley, J.N. Peace and C.J. Nielsen, Biomed. Mass Spectrom., 9 (1981) 219.
39. [39] A. Negro, A.E. Fernandez., A.I. Ortiz, R. Balaña and D. Ordóñez, J. Liq. Chromatogr., 13 (1990) 3849.
40. [40] P. Seppänen, L. Alhonen-Hongisto and J. Jänne, Eur. J. Biochem., 118 (1981) 571.
41. [41] P. Lukkari, J. Jumppanen, K. Jinno, H. Elo and M.-L. Riekkola, J. Pharm. Biomed. Anal., 10 (1992) 561.
42. [42] P. Lukkari, J. Jumppanen, T. Holma, H. Sirén, K. Jinno, H. Elo and M.-L. Riekkola, J. Chromatogr., 608 (1992) 317.
43. [43] M. Koskinen and H. Elo, Spectrosc. Lett., 27 (1994) 889.
44. [44] H. Elo, P. Tilus, I. Mutikainen, I. Heikkinen and M.-L. Riekkola, Anti-Cancer Drug Design, 4 (1989) 303.
45. [45] H. Elo, I. Mutikainen, L. Alhonen-Hongisto, R. Laine, J. Jänne and P. Lumme, Z. Naturforsch., 41c (1986) 851.
46. [46] P.O. Lumme, I. Mutikainen and H.O. Elo, Acta Crystallogr., C42 (1986) 1209.
47. [47] I. Mutikainen, H. Elo and P. Lumme, J. Chem. Soc., Perkin Trans. II, (1986) 291.
48. [48] H. Elo, I. Mutikainen, L. Alhonen-Hongisto, R. Laine and J. Jänne, Cancer Lett., 41 (1988) 21.
49. [49] I. Mutikainen, H. Elo and P. Tilus, Z. Naturforsch., 49b (1993) 1821.
50. [50] H. Elo, Spectrosc. Lett., 22 (1989) 123.
51. [51] H. Elo, Spectrosc. Lett., 22 (1989) 161.
52. [52] H. Elo and K. Soljamo, Spectrosc. Lett., 22 (1989) 1141.